Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionTwo Sigma Securities, Llc
Latest Disclosed Ownership587 shares
Latest Disclosed Value $ 262,119
Two Sigma Securities, Llc ownership in VRTX / Vertex Pharmaceuticals Incorporated

On May 15, 2026 - Two Sigma Securities, Llc filed a 13F-HR form disclosing ownership of 587 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $262,119 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of Vertex Pharmaceuticals Incorporated. The current value of the position is $259,301 USD.

Two Sigma Securities, Llc has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 587 587 262 0.0304
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -5,141 -100.00 0 -100.00
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,141 3,848 297.60 2,289 265.50 0.2823
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,293 1,293 627 0.0951
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -4,205 -100.00 0 -100.00
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,205 -1,016 -19.46 1,956 -20.11 0.0330
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,221 1,269 32.11 2,447 48.21 0.0296
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,952 -31,956 -88.99 1,652 -88.70 0.0159
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 35,908 29,973 505.02 14,611 608.19 0.1412
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,935 4,647 360.79 2,064 355.41 0.0219
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,288 1,288 453 0.0067
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -903 -100.00 0 -100.00
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 903 903 261 0.0078
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -1,309 -100.00 0 -100.00
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,309 -22,994 -94.61 369 -94.18 0.0131
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 24,303 18,557 322.96 6,342 402.54 0.2233
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,746 4,455 345.08 1,262 439.32 0.0549
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,291 1,291 234 0.0069
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -1,529 -100.00 0 -100.00
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,529 -1,299 -45.93 329 -50.75 0.0182
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,828 1,865 193.67 668 154.96 0.0158
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 963 -638 -39.85 262 -43.66 0.0054
2020-09-10 2020-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,601 1,601 66.25 465 77.48 0.0104
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 9,201 9,201 2,671 42,623.5148
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -1,093 -100.00 0 -100.00
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,093 1,093 239 0.0016
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -2,864 -100.00 0 -100.00
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,864 2,864 525 0.0055
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -1,590 -100.00 0 -100.00
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,590 -8,769 -84.65 263 -86.83 0.0032
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,359 -5,297 -33.83 1,997 -24.95 0.0130
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 15,656 15,656 51.13 2,661 33.25 0.0132
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -2,431 -100.00 0 -100.00
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,431 2,431 313 0.0596
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -6,600 -100.00 0 -100.00
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,600 -2,580 -28.10 486 -39.33 0.1625
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 9,180 9,180 39.09 801 64.81 0.2729
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -6,999 -100.00 0 -100.00
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,999 6,999 556 0.7148
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Call 8,400 71.43 3,907 70.12 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Call 4,900 16.67 2,297 30.83 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Call 4,200 13.51 1,756 16.61 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Call 3,700 -36.21 1,505 -25.35 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Call 5,800 -23.68 2,017 -24.61 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Call 7,600 38.18 2,675 54.39 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 5,500 19.57 1,733 30.42 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Call 4,600 318.18 1,328 317.61 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 1,100 318 n/a n/a n/a
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Call 6,600 230.00 1,560 186.76 n/a n/a n/a
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM Call 2,000 -58.33 544 -60.95 n/a n/a n/a
2020-09-10 2020-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 4,800 20.00 1,393 46.32 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Call 4,000 -78.26 952 -76.37 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Call 18,400 11.52 4,029 44.15 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS CALL Call 16,500 251.06 2,795 224.25 n/a n/a n/a
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM Call 4,700 -16.07 862 -16.31 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Call 5,600 -55.20 1,030 -50.27 n/a n/a n/a
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM Call 12,500 -62.46 2,071 -67.73 n/a n/a n/a
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM Call 33,300 5.05 6,418 19.12 n/a n/a n/a
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM Call 31,700 -26.11 5,388 -22.94 n/a n/a n/a
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM Call 42,900 6,992 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Put 4,500 -47.06 2,093 -47.49 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Put 8,500 -11.46 3,984 -0.70 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 9,600 33.33 4,013 36.98 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Put 7,200 -44.19 2,930 -34.69 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Put 12,900 268.57 4,486 264.34 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Put 3,500 29.63 1,232 44.82 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Put 2,700 -55.00 851 -50.92 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Put 6,000 160.87 1,733 160.06 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Put 2,300 666 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Put 8,700 1,911 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Put 1,500 302 n/a n/a n/a
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Put 3,100 40.91 733 22.37 n/a n/a n/a
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM Put 2,200 -21.43 599 -26.32 n/a n/a n/a
2020-09-10 2020-06-30 13F/A VERTEX PHARMACEUTICALS COM Put 2,800 55.56 813 89.95 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Put 1,800 -82.18 428 -80.64 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Put 10,100 83.64 2,211 137.23 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS PUT Put 5,500 61.76 932 49.60 n/a n/a n/a
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM Put 3,400 142.86 623 141.47 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Put 1,400 -81.82 258 -79.78 n/a n/a n/a
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM Put 7,700 -64.52 1,276 -69.49 n/a n/a n/a
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM Put 21,700 -33.84 4,182 -24.99 n/a n/a n/a
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM Put 32,800 485.71 5,575 510.62 n/a n/a n/a
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM Put 5,600 913 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.